Truist Financial analyst David S Macdonald maintained a Hold rating on Amedisys (AMED – Research Report) today and set a price target of ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier. On a ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Sarepta Therapeutics (SRPT – Research Report), Amedisys ...

Amedisys has a twelve month low of $82.15 and a twelve month high of $98.95. Get Amedisys alerts: Amedisys (NASDAQ:AMED – Get Free Report) last announced its quarterly earnings results on ...

Shares of NASDAQ AMED opened at $92.60 on Wednesday. The company’s 50-day simple moving average is $90.11 and its 200-day simple moving average is $93.58. Amedisys has a 52-week low of $82.15 ...

BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month ...

BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month Periods ...

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care. While the top- and bottom-line numbers ...

In light of the pending merger of the Company with UnitedHealth Group Incorporated, Amedisys will not conduct a quarterly earnings call to discuss the fourth quarter and year end results.

Measles is an airborne, "extremely infectious, and potentially severe rash illness," according to the Centers for Disease Control and Prevention ( CDC ). Up to 9 out of 10 people who are susceptible ...

If President Trump's order to rename the Gulf of Mexico to the Gulf of America doesn't feel real yet, maybe this will make it hit home since it's ... well ... close ...